Serina Therapeutics (SER) Depreciation & Amortization (CF) (2018 - 2026)
Serina Therapeutics (SER) posted Depreciation & Amortization (CF) of $24000.0 for Q4 2025, up 50.0% sequentially from $16000.0 in Q3 2025, and down 57.14% YoY from $56000.0 in Q4 2024.
Serina Therapeutics (SER) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Serina Therapeutics has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $24000.0 in Q4 2025.
- Quarterly Depreciation & Amortization (CF) fell 57.14% year-over-year to $24000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $73000.0 (down 62.37% YoY) and the FY2025 annual result came in at $73000.0, down 62.37% from the prior year.
- Depreciation & Amortization (CF) grew to $24000.0 in Q4 2025 per SER's latest filing, from $16000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $227000.0 in Q1 2021 and troughed at $6000.0 in Q4 2023.
- A 4-year average of $44923.1 and a median of $24000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) soared 833.33% in 2024, then tumbled 71.93% in 2025.
- Over 4 years, Depreciation & Amortization (CF) stood at $227000.0 in 2021, then tumbled by 97.36% to $6000.0 in 2023, then jumped by 833.33% to $56000.0 in 2024, then sank by 57.14% to $24000.0 in 2025.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $24000.0, $16000.0, and $16000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18,000.00 |
| Jun 30, 2026 | 18,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |